## SCHW: The Charles Schwab Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($97.15)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Schwab stock slips as Fed minutes put rate outlook back in focus**
- Source: ts2.tech | 20251230T140000 | Somewhat-Bearish | Relevance: 100%
- Charles Schwab Corp's shares fell by 0.6% to $100.69 after opening, with the stock being particularly sensitive to interest-rate expectations given its revenue generation from client cash. Investors are closely watching Federal Reserve minutes for clues on future policy paths, especially regarding potential rate cuts in 2026, which could impact Schwab's net interest income. Additionally, insider transactions show a managing director exercised options and sold shares, while upcoming Q4 results and a Winter Business Update will focus on net new assets and client cash trends.

**2. Charles Schwab (NYSE:SCHW) Insider Jonathan Beatty Sells 2,000 Shares**
- Source: MarketBeat | 20251230T002152 | Neutral | Relevance: 100%
- Jonathan Beatty, an insider at Charles Schwab (NYSE:SCHW), sold 2,000 shares of the company's stock for a total of $204,020. This transaction reduced his holding by 14.36% to 11,923 shares. The company recently reported strong earnings with $1.31 EPS and 26.6% year-over-year revenue growth, and analysts have a "Moderate Buy" rating with a consensus target price of $108.84.

**3. Charles Schwab Corp. stock: quiet rebound, cautious optimism and a market still scarred by last year**
- Source: AD HOC NEWS | 20251229T210225 | Somewhat-Bullish | Relevance: 100%
- Charles Schwab Corp. stock has shown a modest but significant rebound, moving past initial fears stemming from last year's banking shock. While the stock has climbed steadily over several months and seen positive analyst ratings, its valuation remains below its 52-week peak, reflecting cautious optimism and continued sensitivity to interest rate fluctuations. Investors are keenly watching the integration of TD Ameritrade and the broader interest-rate environment for sustained growth.

**4. Cwm LLC Buys 17,370 Shares of The Charles Schwab Corporation $SCHW**
- Source: MarketBeat | 20251229T100808 | Bullish | Relevance: 100%
- Cwm LLC increased its stake in The Charles Schwab Corporation by 16.9%, purchasing an additional 17,370 shares to bring its total holdings to 120,424 shares valued at approximately $11.497 million. Charles Schwab reported strong Q3 results, beating earnings estimates with $1.31 EPS and $6.38 billion in revenue, leading to a "Moderate Buy" consensus rating among analysts and a target price of $108.84. Insider selling by Jonathan S. Beatty and Paul V. Woolway also occurred.

**5. Capricorn Fund Managers Ltd Acquires Shares of 13,307 Apollo Global Management Inc. $APO**
- Source: MarketBeat | 20251228T100919 | Somewhat-Bullish | Relevance: 75%
- Capricorn Fund Managers Ltd has acquired 13,307 shares of Apollo Global Management Inc. (NYSE:APO) in Q3, valued at approximately $1.77 million. This new position contributes to the significant institutional ownership of APO at 77.06%, with other major firms also increasing their stakes. Analysts maintain a "Moderate Buy" rating for the stock, with a consensus target price of $166.23.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $148 | $139 | +6% |
| 2025-12-12 | Barclays | $111 | $115 | -3% |
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.06M) |
| Sells | 15 ($14.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Heavy insider selling: $15M sold (15 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.70 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $182.5B |
| Beta | 0.96 |
| 52W Range | $65.88 - $102.28 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.70 |
| Forward P/E | 17.9 |
| Current P/E | 20.9 |
| YoY Growth | 17.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.3% to 0.5% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.47% (CS: 73) | Neutral |
| RSI_14 | 65.2 | Neutral |
| MACD Histogram | 0.47 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.057x | Above |
| vs SMA200 | 1.111x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $100.57
- **Stop Loss:** $97.15 (3.4% risk)
- **Target:** $103.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 241
- **Position Value:** $24,237.37
- **Portfolio %:** 24.24%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*